DANA BELL: Open Payments
NPI 1073983193 · PLAINS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$963 in 52 payments from 13 companies in 2025. Trend: 2023 $527 · 2024 $751 · 2025 $963
Food & beverage: $873Education: $90
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $209 |
| GlaxoSmithKline, LLC. | 13 | $170 |
| ARS Pharmaceuticals Operations, Inc. | 7 | $149 |
| Regeneron Healthcare Solutions, Inc. | 3 | $71 |
| SANOFI-AVENTIS U.S. LLC | 1 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Genentech USA, Inc. | 3 | $54 |
| Pharming Healthcare, Inc. | 2 | $50 |
| Blueprint Medicines Corporation | 2 | $50 |
| Verona Pharma, Inc. | 2 | $35 |
Products named: TEZSPIRE, NEFFY, DUPIXENT, TRELEGY ELLIPTA, NUCALA, Xolair, RUCONEST, AYVAKIT.
Industry payments across TX — which companies pay providers there.
